Innercap Technologies, Inc. v. Target Corporation d/b/a Target

I'll research this case thoroughly using web search before drafting the overview.

Let me dig deeper into the parallel litigation, the patents, and any IPR activity.

Case Overview: InnerCap Technologies, Inc. v. Target Corporation, No. 0:26-cv-02427 (D. Minn.)

Parties and their businesses. InnerCap Technologies, Inc. is a small Tampa, Florida–based drug-delivery and specialty-pharmaceutical company founded in 2003 that commercializes a multi-phase, "capsule-in-a-capsule" oral delivery platform it markets as NOVACAP®; its CEO, Fred H. Miller, is the named inventor on the patent at issue (US 7,670,612 B2, "[m]ulti-phase, multi-compartment capsular delivery apparatus and methods for using same," assignee InnerCap Technologies, issued Mar. 2, 2010). InnerCap announced the '612 grant in March 2010 as the core of its "multi-phase, multi-compartment technology … commercially manufactured and validated in several products" (SupplySide, Mar. 23, 2010, supplysidesj.com/legal-compliance/innercap-awarded-u-s-patent; patent front page, patentimages.storage.googleapis.com/.../US7670612.pdf). On the spectrum of assertion entities, InnerCap is best characterized as a small operating/technology-licensing company rather than a classic shell NPE — third-party analytics classify it as "Patent Owner / Operating Company," and its Rule 7.1 disclosure states no parent, no publicly held parent, and no subsidiaries (ai-lab.exparte.com/case/dct/mnd/0:26-cv-02427/innercap-tech-inc-v-target-corp; Dkt. 2). It is also not a newcomer to enforcement: the '612 file history references an earlier declaratory-judgment/breach-of-contract fight in which InnerCap answered and counterclaimed against Nutrex Research, Inc., and the company has previously used New York patent counsel on the portfolio. Defendant Target Corporation is the Minneapolis-headquartered national mass retailer, sued here in its capacity as a seller of the accused supplements. Plaintiff's counsel of record on the Minnesota docket includes Mark Bradford (Bradford, Andresen, Norrie & Camarotto) and attorneys from Folio Law Group (Cristofer Leffler, Michael C. Saunders II, Katherine Bentfield, Aden Allen) (Justia docket, dockets.justia.com/docket/minnesota/mndce/0:2026cv02427/233657; PacerMonitor, pacermonitor.com/public/case/64416119). Target-side appearances are not clearly attributable from the sources I could retrieve, so I won't name them with confidence.

Accused technology and asserted patents. The complaint, filed April 30, 2026, accuses Target of infringing by selling the "Ritual" vitamin line — i.e., third-party-branded, nested-capsule supplements such as Ritual's prenatal multivitamins, in which an oil-based ingredient (e.g., omega-3 DHA) sits in the outer capsule and dry/solid ingredients sit in a delayed-release inner capsule (Bloomberg Law report, May 1, 2026, via cbinsights.com/company/innercap-technologies). The asserted '612 patent claims a multi-compartment hard-shell capsule in which a first receiving chamber contains an oil in immediate-release form and a second, enveloped chamber contains only solid ingredients formulated for time-delayed dissolution, with the chambers holding different ingredients; the complaint in the parallel InnerCap case pleads at least independent claim 33 as representative (US 7,670,612 B2, claim 33/abstract; complaint analysis at ai-lab.exparte.com/case/dct/ded/1:26-cv-00488/doc/analysis/1). In one sentence each: the '612 patent covers a capsule-in-capsule dosage form that keeps chemically incompatible solid and liquid/oil actives physically separate while allowing staged release; the '216 patent (listed in the case metadata as also at issue) appears to be a later InnerCap filing from the same supplement/dosage-form family — a January 2016 application that granted January 10, 2017, per

I'll research the docket history and related proceedings for this case.

Key Legal Developments & Current Posture — InnerCap Techs., Inc. v. Target Corp., No. 0:26-cv-02427 (D. Minn.)

Threshold sourcing caveat (read first)

This is a five-and-a-half-month-old, pleading-stage case. The most recent docket event list I can retrieve still terminates at the filing date — Justia and PacerMonitor both render the event list as "Docket last updated: 04/30/2026 3:21 PM CDT," with entries 1–6 only (Justia docket; PacerMonitor). Case-tracking aggregators independently list the case as "Status: Open" with no disposition (Ex Parte case page).

I therefore cannot report an answer, a Rule 12 motion, a Markman order, a scheduling order, or any discovery event in this case, because no such event is documented in any retrievable source. What I can do — and what follows — is (a) pin down every documented event in this case with docket numbers, (b) report the documented procedural history of the four-case InnerCap campaign that directly controls this case's trajectory, and (c) flag the two places where the record is inconsistent. I have marked speculation as speculation.

---

1. Chronology — documented events in this case

That is the entire documented record. No answer, no Rule 12 motion, no counterclaim, no Rule 26(f) report, no scheduling order, and no Markman filing is retrievable.

2. Filing & initial pleadings — what is and is not documented

• Complaint (Dkt. 1): asserts infringement of US 7,670,612, pleading at least independent claim 33 as representative and reserving other claims. Claim 33 requires (i) a first receiving chamber with at least one oil in immediate-release form, (ii) a second chamber containing only solid ingredients, with a solid active "formulated in a manner allowing for a time-delayed dissolution and release," (iii) different ingredients in each chamber, (iv) the second chamber enveloped by the first, and (v) a hard-shell capsule. Accused: Target's sale of the Ritual nested-capsule line (e.g., Ritual Essentials Prenatal Multivitamins — omega-3 DHA in the outer shell, dry water-soluble vitamins in the inner capsule). See the parallel complaint analysis at Ex Parte, InnerCap v. Walmart, No. 1:26-cv-00488, Doc. 1 analysis (same claim 33, same accused Ritual product) and the May 1, 2026 Bloomberg Law report as summarized at CB Insights.
• Answer/counterclaims: NOT DOCUMENTED. PacerMonitor's party block attributes Carla Baumel and Christopher A. Pinahs (Robins Kaplan LLP) and Christopher W. Bowman (Madigan, Dahl & Harlan, P.A.) to the defense side, but because the event list truncates at 4/30/2026, I cannot cite an appearance or answer docket number. Treat Target's appearance as highly likely but unconfirmed. (This refines, rather than contradicts, the earlier Defendant Representatives section.)
• '216 patent: NOT CONFIRMED AS ASSERTED. Every retrievable InnerCap complaint in the 2026 campaign — Target, Walmart, Nouri, Natals — asserts only the '612. Nothing I found ties US 9,539,216 to this complaint. ⚠️ Flagged contradiction with governing metadata, which lists both patents; I defer to the metadata on what is "at issue" but note the docket does not yet corroborate the '216's assertion.

3. Pre-trial motions of substance (dismissal / transfer / stay / summary judgment)

None documented in this case. No Rule 12(b) motion, no § 1404(a) transfer motion, no motion to stay pending IPR, and no summary-judgment motion appears in any retrievable source.

What has happened in the campaign is directly probative of how this case is likely to move, and is documented:

Sources: PacerMonitor InnerCap v. Walmart (docket entries 13–19, including the 8/24/2026 stay order); PacerMonitor InnerCap v. Nouri Life (default request, PHV order 8/28/2026); Delaware docket mirror for 1:26-cv-00488.

Speculation, clearly labeled: Given (i) Target is a downstream retailer selling a third-party-branded product, (ii) the brand owner (Natals/Ritual) is now itself a defendant in Delaware, and (iii) InnerCap stipulated to stay the Walmart case behind Natals/Nouri, the most probable near-term Target-side motions are a stay pending the Delaware brand-owner cases and/or an indemnification-driven deferral. I found no filing confirming either.

4. Claim construction (Markman)

Not reached. No Markman order, joint claim-construction statement, or Indefiniteness/§ 112 ruling exists — the case has not progressed past the pleadings on any retrievable record.

Worth flagging for the eventual Markman fight: the claim-33 limitations most exposed are "only solid ingredients," "formulated in a manner allowing for a time-delayed dissolution and release" (a functional/result-oriented limitation inviting § 112(f) or indefiniteness attack), and "hard shell capsule." The complaint's infringement theory for the delayed-release element leans on the accused products' own marketing copy (inner capsule "designed for delayed release"), which is a vulnerability if Target and Natals contest that the inner shell is structurally distinct. See complaint analysis, 1:26-cv-00488 Doc. 1 ("Identified Points of Contention").

5. Discovery milestones

None documented. No Rule 26(f) conference, no scheduling order, no protective order, no ESI order, no infringement/invalidity contentions, and no discovery motions are retrievable. D. Minn. practice would put a Rule 16 conference and scheduling order on a track of roughly 60–90 days post-appearance, but no such order is in the record I can access.

6. Trial, verdict, post-trial motions

**

I'll research this case's docket and counsel filings through multiple sources.

Let me dig into individual counsel and related Innercap filings.

Good progress. Let me verify each attorney's firm affiliation and role.

Counsel of Record — Plaintiff InnerCap Technologies, Inc.

Important sourcing caveat up front: the D. Minn. docket for 0:26-cv-02427 was last retrieved April 30, 2026 and contains only six entries (complaint, Rule 7.1 disclosure, notice of appearance, clerk's notice, summons, AO-120 report). No pro hac vice motions, no amended notices of appearance, and no scheduling order appear yet on the public docket. Some of what follows is therefore drawn from (a) the signature block on the complaint itself and (b) InnerCap's parallel, further-along litigation where the same team has formally appeared — not from Minnesota-side appearance filings, which do not yet exist.

Plaintiff-side counsel

1. Mark R. Bradford — Minnesota counsel of record (local/lead on the docket)

• Firm: Bradford, Andresen, Norrie & Camarotto, PLLP — 3600 American Blvd W, Suite 670, Bloomington, MN 55431 (firm profile).
• Basis: He is the only attorney who has appeared for InnerCap on this docket — Dkt. 3, Notice of Appearance, and he filed Dkt. 1 (Complaint) and Dkt. 6 (AO 120 report). Docket entry text confirms "(Bradford, Mark)" as filer (Docket sheet).
• Experience note: Bradford is a Chambers-ranked appellate and complex commercial litigator (Band 2, Litigation: Appellate – Minnesota) who has argued 100+ appeals; his profile is not patent-centric, which is consistent with a local-counsel role carrying the filings while a national IP boutique runs the patent case (Chambers). He is also the firm name credited as Plaintiffs' Counsel in the May 2026 Retail Patent Litigation Report entry for this case (Lexology).

2. Cristofer Ivan ("Cris") Leffler — lead counsel (national patent counsel)

• Firm: Folio Law Group PLLC — 1200 Westlake Ave. N., Suite 809, Seattle, WA 98109 (206-512-9051).
• Basis: Law360 lists him on "April 30, 2026 Innercap Technologies, Inc. v. Target Corporation, Minnesota" (Law360 profile); PacerMonitor's party block for this case lists "Cristofer Leffler — Folio Law Group PLLC" (PacerMonitor).
• Experience note: Founder/managing partner of Folio; 25+ years in patent litigation and IP monetization; former senior roles at Dorsey & Whitney and K&L Gates and Director of IP Litigation at Intellectual Ventures; lead trial counsel in a multi-million-dollar counterclaim verdict and in Netlist v. Monolithic Power Systems (firm bio). Cal. Bar #208129, admitted 2000.

3. Michael Craig Saunders (II) — Folio Law Group PLLC, Seattle

• Basis: Listed alongside Leffler and Bentfield on PacerMonitor's entry for this case; on Folio's team in i4F Licensing NV v. Hangzhou Hanhent and in InnerCap's matters (PacerMonitor i4F); listed among Folio attorneys practicing IP litigation (Lawyer.com).
• Role: Member of the InnerCap national patent team (appears on InnerCap pleadings in other districts).

4. Katherine Bentfield — Folio Law Group PLLC, Seattle (associate)

• Basis: PacerMonitor party list for this case; she has executed PTAB declarations as "attorney at Folio Law Group, PLLC" (e.g., IPR2022-01345, Ex. 2018) and appeared for patent owners/clients including Dali Wireless and Pinn Audio (Folio bio; PTAB exhibit). Joined Folio in 2023.
• Role: Junior associate supporting the InnerCap team; not yet formally on the D. Minn. docket.

5. Aden M. Allen — InnerCap litigation team (firm not confirmed)

• Basis: Named in PacerMonitor's party block for this case, and admitted pro hac vice for INNERCAP Technologies, Inc. in the parallel Delaware action, INNERCAP Technologies, Inc. v. Walmart Inc., 1:26-cv-00488 (D. Del.) (PHV motion granted May 14, 2026) (D. Del. docket).
• Caveat: I could not confirm from the retrieved sources whether Allen is at Folio Law Group or another firm in InnerCap's roster. Treat firm affiliation as unverified.

Not plaintiff's counsel — flag to avoid mis-attribution

The PacerMonitor party block for this case intermixes both sides. The following appear in it but are most consistent with Target's defense team, and I have not treated them as plaintiff's counsel:

• Carla Baumel and Christopher A. Pinahs — Robins Kaplan LLP (Minneapolis).
• Christopher W. Bowman — Madigan, Dahl & Harlan, P.A. (Minneapolis).

I could not retrieve a Minnesota pro hac vice order or notice of appearance confirming which firm represents Target in this case; that attribution is inference, not a verified filing.

Context that corroborates the plaintiff team

InnerCap is a serial filer asserting US 7,670,612 (multi-phase, multi-compartment capsular delivery). The same roster appears across its 2026 campaign — v. Walmart (D. Del. 1:26-cv-00488, Apr. 27, 2026), v. Nouri Life (D. Del. 1:26-cv-00903, filed July 24, 2026), and v. Natals (1:26-cv-00823, July 8, 2026) — with Folio Law Group as national patent counsel and Bradford, Andresen, Norrie & Camarotto serving as the Minnesota-side firm (Lexology report; Patexia docket index; Ex Parte complaint analysis).

Bottom line

• Lead/patent counsel: Cristofer I. Leffler (Folio Law Group PLLC, Seattle), supported by Michael C. Saunders and Katherine Bentfield (same firm), with Aden M. Allen as a further team member (firm unverified).
• Counsel formally on the Minnesota docket: only Mark R. Bradford (Bradford, Andresen, Norrie & Camarotto, Bloomington, MN), who signed and filed Dkts. 1, 3, and 6.
• Status caveat: no Folio attorney has yet appeared in D. Minn. as of the last public docket pull (Apr. 30, 2026); expect pro hac vice motions and appearances if this case follows the pattern of InnerCap's Delaware filings. No sealing issues are apparent, but the docket is simply too early to be complete.

I'll research Target's counsel in this case through docket sources, firm announcements, and litigation databases.

Let me verify which of those attorneys represent Target (as opposed to InnerCap) and look for appearances and answers filed after the initial docket snapshot.

Defendant's Counsel of Record — InnerCap Technologies, Inc. v. Target Corporation, No. 0:26-cv-02427 (D. Minn.)

Bottom line up front: The docket snapshot available for this case (Justia, "last retrieved April 30, 2026") shows filings 1–6 only, all filed by plaintiff's side on the day of filing — there is no Target-side appearance, answer, or Rule 7.1 disclosure visible in that snapshot. However, the PacerMonitor docket page for the case (last checked mid-2026) lists a defendant-side representation block containing Robins Kaplan LLP and Madigan, Dahl & Harlan, P.A. Based on that plus firm/attorney verification, Target's identified defense team is:

No in-house counsel for Target is identified in any source I could retrieve; all three above are outside counsel.

Confidence and sourcing caveats (please read)

1. No docket entry numbers can be cited for defense counsel. The complaint-stage docket (Dkts. 1–6) contains only plaintiff's filings — Notice of Appearance by Mark Bradford (Dkt. 3), Rule 7.1 statement for InnerCap (Dkt. 2), Complaint (Dkt. 1), Summons (Dkt. 5), AO-120 patent report (Dkt. 6). I am not asserting that Baumel, Pinahs, or Bowman filed a specific numbered appearance, because I could not retrieve any notice of appearance or answer for Target. Their names come from PacerMonitor's aggregated party/attorney mapping for this case (pacermonitor.com/public/case/64416119), not from a docket entry I could read.
2. Party attribution is an inference, but a well-supported one. PacerMonitor's page lists the attorneys in a single block; I sorted them by cross-checking which lawyers appear for InnerCap in InnerCap's three parallel 2026 suits — Mark Bradford (Bradford, Andresen, Norrie & Camarotto) and Folio Law Group attorneys Cristofer Leffler, Michael C. Saunders II, Katherine Bentfield, and Aden M. Allen are consistently plaintiff-side in InnerCap v. Walmart (D. Del. 1:26-cv-00488), InnerCap v. Nouri Life (D. Del. 1:26-cv-00903), and D. Minn. 0:26-cv-02427. Baumel/Pinahs (Robins Kaplan) and Bowman (Madigan Dahl) are not on any InnerCap filing, and Robins Kaplan is a Minneapolis firm historically used by Target for IP defense — so they map to the defendant. The Lexology May 2026 Retail Patent Litigation Report independently lists only "Pls. Cnsl: Bradford Andresen Norrie & Camarotto" for this case, consistent with Target not having appeared as of that report.
3. Lead vs. local counsel allocation is my characterization, not a court designation. Given Pinahs' life-sciences/pharma patent practice and Baumel's IP/PTO background, it is likely Robins Kaplan is Target's principal patent-defense firm, with Madigan, Dahl & Harlan possibly serving a Minnesota-local function — but Target has in the past staffed retail IP defense with more than one firm, and roles may be different here. Treat the "role" column as provisional.
4. Sealed/absent filings. There is nothing in the retrievable record indicating any filing is sealed; the more likely explanation is simply that the freely indexed docket snapshots for this case stop on the filing date (both Justia and PacerMonitor show "docket last updated: 04/30/2026 3:21 PM CDT" for the event list). Later entries are behind PACER.

Useful adjacent context on who is representing whom in the related InnerCap web (not Target's counsel)

• Natals, Inc. d/b/a Ritual v. InnerCap Technologies, Inc., C.D. Cal. 2:26-cv-05696 — a declaratory-relief action brought by the Ritual brand owner (not by Target). Ritual's counsel of record there is Melissa N. Eubanks (VGC LLP) — relevant because it confirms the accused "Ritual" products are supplied/branded by a third party, which may explain Target's expected supplier-indemnification posture here and why multiple defense firms may be involved (cdn.pacermonitor.com/public/case/64868909).
• InnerCap's own Delaware counsel in the parallel suits is Farnan LLP (Brian E. Farnan, Michael J. Farnan) with Folio Law Group as lead (D. Del. 1:26-cv-00488, 1:26-cv-00903).

Recommended verification steps (I could not complete these)

1. PACER docket for 0:26-cv-02427, entries 7 and later — look for "NOTICE of Appearance" and "ANSWER" from Robins Kaplan / Madigan Dahl, and Target's Rule 7.1 disclosure; that will convert the entries above into citable docket numbers.
2. Check whether Target filed a motion to dismiss, motion to transfer/consolidate, or a stay pending IPR (no such filing is visible in the April 30 snapshot).
3. Docket Navigator or Law360's case page (Law360 already indexes Folio Law Group attorney Cristofer Leffler to this case: law360.com/firms/folio-law-group/attorneys/cristofer-leffler) for the firm-by-firm "lead counsel / other counsel" breakdown on the defense side.

Flagging one inconsistency with the earlier-generated overview: that section stated Target-side appearances "are not clearly attributable from the sources I could retrieve." The PacerMonitor defendant representation block materially improves on that — it does attribute Robins Kaplan LLP and Madigan, Dahl & Harlan, P.A. to the defendant — but because the underlying appearances are not in the retrievable docket text, I am presenting them as highly likely rather than confirmed. Also, per the governing metadata, the patents at issue are 7,670,612 and 9,539,216; the Lexology report and complaint analysis I found only identify the '612 patent as asserted in the Target and Nouri complaints, so the '216's asserted status in this case remains unverified from the sources retrieved.